According to the medicines' SmPCs, no dose adjustment is generally required for patients with mild to moderate hepatic impairment
Leg cramps are not unique to semaglutide, but they can be troubling when they occur
A commonly used regimen is a loading phase of 25 mg per week (subcutaneous injection) for 46 weeks, followed by a maintenance dose of around 2 mg every 12 weeks
This would be especially true for drugs relying on a fine functional remodulation of a well preserved cellular system, like the NRF2 activators on the KEAP1-NRF2 system
Over the last few decades, therapeutic development of nanomedicine at preclinical stage has shown to progress at a fast pace, thus paving the way for its potential impact on human health in improving prevention, diagnosis, and treatment of age-related neurodegenerative disorders, including AD
Phytosphingosine is a novel activator of GPR120